Illumigyn
Neve Ilan
About Illumigyn
Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications in an effort to eliminate the inherent subjectivity of cervical exams. Its Gynescope is a patented imaging colposcope that delivers 15-micron image resolution over a wide field of view and a range of working distances. The Gynescope also has multispectral illumination options, allowing early detection of cervical cancer while meaningfully reducing misdiagnoses. The Gynescope enables sophisticated imaging with simultaneous complex interventional procedures to support the best clinical outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.0M
- Last round: Series Unknown (Nov 2021)
- Website: illumigyn.com
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Medical Device, Product Design
Social Profiles
Canonical: https://fsome.com/organization/illumigyn-31474 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.